VIBOSTOLIMAB

UNII:	5XO3JF0FEK
Formula:
Preferred Substance Name:	VIBOSTOLIMAB
GSRS Full Record:	5XO3JF0FEK i

2231305-30-7
IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR TIGIT (T-CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS)) (HUMAN-MUS MUSCULUS MONOCLONAL C011 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL C011 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS T-CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS, V-SET AND IMMUNOGLOBULIN DOMAIN-CONTAINING PROTEIN 9, V-SET AND TRANSMEMBRANE DOMAIN-CONTAINING PROTEIN 3)HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN HUMANIZED (1-449) (VH (HOMO SAPIENS IGHV1-69*08 (85%) (IGHD)-IGHJ3*01 (93%)) (8.8.12) (1-119)-HOMO SAPIENS IGHG1*01 (100%) (120-449)) (222-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-27*01 (85%) IGKJ5*01 (92%))(6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (100%) (108'-214')), DIMER (228-228'':231-231'')-BISDISULFIDE
MK7684
MK-7684
MK-7684A COMPONENT VIBOSTOLIMAB
T-CELL IMMUNOGLOBULIN AND IMMUNORECEPTOR TYROSINE-BASED INHIBITORY MOTIF INHIBITOR MK-7684
TIGIT INHIBITOR MK-7684
TIGIT-TARGETING AGENT MK-7684
VIBOSTOLIMAB [INN]
VIBOSTOLIMAB [USAN]
VIBOSTOLIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

VIBOSTOLIMAB

Synonyms and Mappings

Resources